|4Oct 5, 8:42 PM ET

Arsenault Kaitlyn Melanie 4

4 · Skye Bioscience, Inc. · Filed Oct 5, 2021

Insider Transaction Report

Form 4
Period: 2021-10-04
ARSENAULT KAITLYN
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2021-10-04+1,600,0002,000,000 total
    Exercise: $0.09Exp: 2031-10-04Common Stock (1,600,000 underlying)
Footnotes (1)
  • [F1]10% of the Options shall vest on October 4, 2021 (the "Vesting Start Date") and the remaining 90% of the Options will vest in equal semi-annual installments over four annual periods.

Documents

1 file
  • 4
    wf-form4_163348095684882.xmlPrimary

    FORM 4